| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$681 |
Update - Notification of buy-back - FPR
|
4 Jun 2025 8:27AM |
$2.970 |
$3.070 |
risen by
3.37%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$515 |
Tyro Appoints New Director
|
4 Jun 2025 8:26AM |
$0.885 |
$0.975 |
risen by
10.17%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$54 |
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
|
4 Jun 2025 8:26AM |
$0.026 |
$0.023 |
fallen by
11.54%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited (RAD) announced the dosing of the first patient in its Phase 1 therapeutic clinical trial of 177Lu-RAD202.
- RAD202 is a novel radiotherapeutic being developed for the treatment of specific cancer types.
- The trial is a first-in-human study designed to evaluate the safety, tolerability, and preliminary efficacy of 177Lu-RAD202.
- The first patient was dosed at the Princess Alexandra Hospital in Brisbane, Australia.
- This milestone represents a significant step in RAD's clinical development pipeline and aligns with the company's growth strategy.
- RAD202 targets the CD3 receptor, a marker present in various cancer types, using a radiolabeled antibody approach.
- The trial's initial phase will focus on safety and dose escalation to determine the maximum tolerated dose.
- Future trial phases may assess efficacy in a wider patient population based on initial safety data.
- Radiopharm Theranostics Limited specializes in radiopharmaceutical products for diagnostic and therapeutic purposes in oncology.
- The announcement underscores RAD's commitment to advancing innovative cancer therapies using targeted radionuclide technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$23,165 |
Statement of Changes in Beneficial Ownership
|
4 Jun 2025 8:26AM |
$37.930 |
$39.720 |
risen by
4.72%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,872 |
Final Director's Interest Notice - RYAN
|
4 Jun 2025 8:26AM |
$17.540 |
$18.880 |
risen by
7.64%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,691 |
Notification of cessation of securities - ORA
|
4 Jun 2025 8:26AM |
$1.885 |
$2.100 |
risen by
11.41%
|
|
| Minerals 260 Limited (MI6) ORDINARY FULLY PAID |
Materials |
$248 |
Bullabulling Gold Project Drilling Results
|
4 Jun 2025 8:26AM |
$0.145 |
$0.120 |
fallen by
17.24%
|
|
MI6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Minerals 260 Limited (MI6) released its first 2024 drilling results from the Bullabulling Gold Project.
- Significant gold mineralisation was intersected at Gibraltar, Phoenix, and Elvire prospects.
- Reverse circulation (RC) drilling confirmed thickness and grade of gold intercepts.
- Results indicate strong potential for resource growth and further exploration.
- Initial drilling focused on expanding known mineralised zones and testing new targets.
- Ongoing drilling will continue to refine and extend current findings.
- Bullabulling Gold Project is shaping up as a potential significant gold resource in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$52 |
Change of Director's Interest Notice
|
4 Jun 2025 8:26AM |
$0.680 |
$0.665 |
fallen by
2.21%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$128 |
Update - Notification of buy-back - VVA
|
4 Jun 2025 8:25AM |
$1.310 |
$1.255 |
fallen by
4.20%
|
|
| OFX Group Limited (OFX) ORDINARY FULLY PAID |
Financials |
$174 |
AGM and Nomination of Directors
|
4 Jun 2025 8:25AM |
$0.690 |
$0.745 |
risen by
7.97%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,691 |
Update - Notification of buy-back - ORA
|
4 Jun 2025 8:25AM |
$1.885 |
$2.100 |
risen by
11.41%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,872 |
Notification of cessation of securities - ZIP
|
4 Jun 2025 8:25AM |
$1.945 |
$3.000 |
risen by
54.24%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$382 |
Notification of cessation of securities - NVX
|
4 Jun 2025 8:25AM |
$0.400 |
$0.600 |
risen by
50%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$98 |
Update - Notification of buy-back - M7T
|
4 Jun 2025 8:25AM |
$0.370 |
$0.415 |
risen by
12.16%
|
|
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$739 |
Notification of cessation of securities - RUL
|
4 Jun 2025 8:25AM |
$3.080 |
$3.350 |
risen by
8.77%
|
|
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$739 |
Update - Notification of buy-back - RUL
|
4 Jun 2025 8:25AM |
$3.080 |
$3.350 |
risen by
8.77%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$1,881 |
Net Tangible Asset Backing
|
4 Jun 2025 8:25AM |
$2.780 |
$2.990 |
risen by
7.55%
|
|
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,827 |
Update - Notification of buy-back - FLT
|
4 Jun 2025 8:25AM |
$12.890 |
$12.980 |
risen by
0.70%
|
|
| Regis Resources Limited (RRL) ORDINARY FULLY PAID |
Materials |
$3,250 |
Analyst Site Visit-Tropicana
|
4 Jun 2025 8:25AM |
$5.310 |
$4.300 |
fallen by
19.02%
|
|
| Coronado Global Resources Inc (CRN) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$285 |
ABL Binding Commitment
|
4 Jun 2025 8:25AM |
$0.105 |
$0.170 |
risen by
61.90%
|
|
CRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Coronado Global Resources Inc (CRN) announced a binding commitment for a new US$350 million Asset-Based Lending (ABL) Facility.
- The ABL Facility will replace the existing syndicated facility and provide greater financial flexibility.
- The facility is structured as a revolving credit facility, supporting working capital and general corporate purposes.
- Multiple leading international banks are participating in the syndicate of the ABL Facility.
- The terms of the ABL Facility include improved pricing, increased tenor, and enhanced covenant flexibility compared to the previous facility.
- The ABL Facility is expected to close imminently, subject to customary conditions precedent.
- CRN’s Board and management highlighted the importance of a strong balance sheet and disciplined capital management.
- The company sees the new facility as supporting ongoing operations and enabling the pursuit of strategic growth initiatives.
- CRN will continue to monitor financial market conditions and adapt its capital structure as necessary to maximize shareholder value.
- The announcement reiterates CRN’s focus on maintaining liquidity, financial strength, and operational flexibility as key priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$42 |
Proposed issue of securities - CYP
|
4 Jun 2025 8:24AM |
$0.170 |
$0.185 |
risen by
8.82%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$298 |
Update - Notification of buy-back - SVR
|
4 Jun 2025 8:24AM |
$1.685 |
$1.535 |
fallen by
8.90%
|
|
| Waypoint REIT Limited (WPR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,622 |
Update - Notification of buy-back - WPR
|
4 Jun 2025 8:24AM |
$2.660 |
$2.460 |
fallen by
7.52%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$10 |
Cann Settles Legal Dispute with Rua Biosciences
|
4 Jun 2025 8:24AM |
$0.014 |
$0.016 |
risen by
10.71%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Cann Group Limited has settled its legal dispute with Rua Biosciences.
- The dispute involved a previous supply agreement and associated legal claims.
- All legal actions between the companies will be withdrawn.
- Both parties have agreed not to pursue any further claims relating to the dispute.
- No admission of liability has been made by either Cann Group or Rua Biosciences.
- The settlement enables both companies to focus on business operations and future opportunities.
- Cann Group remains committed to its commercial relationships and growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,308 |
Update - Notification of buy-back - DNL
|
4 Jun 2025 8:24AM |
$2.640 |
$2.900 |
risen by
9.85%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
